The global kidney and pancreas transplant market is anticipated to grow at a significant CAGR of 9.7% during the forecast. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/global-kidney-and-pancreas-transplant-market
For instance-
April 2021- The US FDA has approved Farxiga oral tablets which reduce the risk of kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney diseases. The FDA granted Farxiga to Astra Zeneca.
July 2021- The FDA approved finerenone, a nonsteroidal mineralocorticoid receptor antagonist for the treatment of patients with chronic kidney disease(CKD9, associated with type 2 diabetes. The drug works to slow the chronic kidney disease progression and assists in reducing the risk of kidney failure, heart attack, or cardiovascular death in patients with CKD associated with T2D.
December 2021- The US FDA has cleared the ovarian cancer drug Lynparza to treat advanced pancreatic cancer. This treatment assists to treat the pancreas and whose tumors did not grow after at least 16 weeks of chemotherapy.
Global Kidney and Pancreas Transplant Market– Segmentation
By Sources
- Living Donors
- Deceased Donors
By Treatment
- Analgesic
- Immunosuppressant
- Others
By End User
- Hospitals
- Transplant Centers
- Others
A full report of Kidney and Pancreas Transplant Market is available at: https://www.omrglobal.com/industry-reports/global-kidney-and-pancreas-transplant-market
Kidney and Pancreas Transplant Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Arthrex GmbH
- Bio-Rad
- CareDx Inc
- Franz Köhler Chemie GmbH
- Hoffmann-La Roche Ltd.
- Luminex
- Organ Recovery Systems Inc.
- Organogenesis
- Sanofi US
- Stryker
- Teva Pharmaceutical Industries Ltd.
- Veloxis Pharmaceuticals
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
